HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human breast cancer cells and normal mammary epithelial cells: retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol.

Abstract
To understand the signaling and growth-inhibitory effects of retinoids, we have examined the metabolism of [3H]retinol in a number of estrogen receptor-positive (ER+) and estrogen receptor-negative (ER-) human breast cancer cell lines. We have also assayed the metabolism of [3H]retinol in normal human mammary epithelial cells. The ER+ breast cancer cell lines MCF-7 and T47D produce [3H]4-oxoretinol from [3H]retinol; the production of [3H]4-oxoretinol is increased by initial culture in the presence of nonradiolabeled retinoic acid (RA) or N-(4-hydroxyphenyl)retinamide, indicating that these drugs enhance [3H]retinol metabolism to [3H]4-oxoretinol. No metabolism of [3H]retinol to [3H]RA in these ER+ tumor lines was detected. ER- breast cancer lines MDA-MB-231, MDA-MB-468, and BT20 do not metabolize [3H]retinol to [3H]4-oxoretinol. In the ER- tumor lines, most of the [3H]retinol remains unmetabolized during the 24-h culture period; MDA-MB-468 and BT20 metabolize some [3H]retinol to [3H]RA. Unlike the majority of the tumor lines, the normal human breast epithelial cell strains AD074 and MCF10A rapidly metabolize [3H]retinol to [3H]retinyl esters. No detectable [3H]RA is produced from [3H]retinol in AD074 and MCF10A cells. Thus, the normal breast epithelial strains, the ER+ tumor lines and the ER- tumor lines differ greatly in their pathways of [3H]retinol metabolism. The levels of cellular retinol binding protein-I mRNA expression are not correlated with the levels or types of various retinol metabolites. Whereas the normal breast epithelial cells and the ER+ tumor lines are growth inhibited by RA, N-(4-hydroxyphenyl)retinamide, and 4-oxoretinol, only the 4-oxoretinol is growth inhibitory in the ER- tumor lines. The cellular retinoic acid-binding protein II mRNA levels are not correlated with the growth inhibition by RA or 4-oxoretinol in the normal and tumor lines.
AuthorsA C Chen, X Guo, F Derguini, L J Gudas
JournalCancer research (Cancer Res) Vol. 57 Issue 20 Pg. 4642-51 (Oct 15 1997) ISSN: 0008-5472 [Print] United States
PMID9377581 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • RBP1 protein, human
  • RBP2 protein, human
  • RNA, Messenger
  • Retinol-Binding Proteins
  • Retinol-Binding Proteins, Cellular
  • Tritium
  • Vitamin A
  • 4-oxoretinol
Topics
  • Breast (cytology)
  • Breast Neoplasms (metabolism)
  • Cell Division (drug effects)
  • Cell Line
  • Chromatography, High Pressure Liquid
  • Epithelial Cells (cytology, drug effects, metabolism)
  • Female
  • Humans
  • Kinetics
  • RNA, Messenger (biosynthesis)
  • Retinol-Binding Proteins (biosynthesis)
  • Retinol-Binding Proteins, Cellular
  • Transcription, Genetic
  • Tritium
  • Tumor Cells, Cultured
  • Vitamin A (analogs & derivatives, metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: